Nova Mentis Life Science (Nova Mentis Life Science) Accounts Payable & Accrued Expense : $0.69 Mil (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Nova Mentis Life Science Accounts Payable & Accrued Expense?

Nova Mentis Life Science's quarterly accounts payable & accrued expense increased from Mar. 2023 ($0.25 Mil) to Sep. 2023 ($0.48 Mil) and increased from Sep. 2023 ($0.48 Mil) to Mar. 2024 ($0.69 Mil).

Nova Mentis Life Science's annual accounts payable & accrued expense increased from Dec. 2020 ($0.30 Mil) to Dec. 2021 ($0.33 Mil) but then declined from Dec. 2021 ($0.33 Mil) to Dec. 2022 ($0.19 Mil).

Nova Mentis Life Science Accounts Payable & Accrued Expense Historical Data

The historical data trend for Nova Mentis Life Science's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nova Mentis Life Science Accounts Payable & Accrued Expense Chart

Nova Mentis Life Science Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.23

0.25

0.30

0.33

0.19

Nova Mentis Life Science Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															0.17	0.19	0.25	0.48	0.69

Nova Mentis Life Science Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Nova Mentis Life Science (Nova Mentis Life Science) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nova Mentis Life Science Corp (OTCPK:NMLSF) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

HN3Q:Germany NOVA:Canada

Address

700-838 West Hastings Street, Vancouver, BC, CAN, V6C 0A6

Website

https://www.novamentis.ca

Nova Mentis Life Science Corp is a Canadian-based biotechnology company. It is engaged in developing diagnostics and psilocybin-based therapeutics for neuroinflammatory disorders. Nova uses psilocybin in the treatment of Fragile X Syndrome (FXS). The company's goal is to diagnose and treat debilitating chronic conditions that have unmet medical needs such as autism spectrum disorder (ASD) and FXS. It has one industry segment, being research and development of psilocybin, and in one geographic area, which is Canada.